(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXCEED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EXCEED

ST13

US500000086373637

Class

1

Filing

86373637

Registration

5082668

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

11/16/2025

Trademark type

Word

Nice classes

1

Filing date

08/21/2014

Registration date

11/15/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/06/2023

Last transaction

11/16/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/31/2015

First use in commerce

01/31/2015

Drawing code

4

Owner type

16

Owner location

Henrietta, TX

Examiner

CHANG,ELIZABETH YI HSUAN

Law office

M60

Current location

TMO LAW OFFICE 115

Holders and representatives

Holders

Visjon Biologics, LLC
Visjon Biologics, LLC

Representatives

Charles P. Schmal Woodard, Emhardt, Henry, Reeves & Wagner, LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in agricultureseed inoculants and plant-growth promoters for legume crops

Publications

History of USPTO decisions and trademark events.

37 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/15/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/06/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/06/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/06/2023

E815

TEAS SECTION 8 & 15 RECEIVED

09/27/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/15/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/30/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/30/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/15/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/11/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/10/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/07/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/07/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/07/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/16/2016

GNRT

NON-FINAL ACTION E-MAILED

05/16/2016

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/16/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/13/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/11/2016

IUAF

USE AMENDMENT FILED

04/11/2016

EISU

TEAS STATEMENT OF USE RECEIVED

04/11/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/13/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/18/2015

PUBO

PUBLISHED FOR OPPOSITION

08/18/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/29/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/11/2015

ALIE

ASSIGNED TO LIE

07/10/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/26/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/27/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/27/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/05/2014

GNRT

NON-FINAL ACTION E-MAILED

12/05/2014

CNRT

NON-FINAL ACTION WRITTEN

12/05/2014

DOCK

ASSIGNED TO EXAMINER

12/05/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/04/2014

NWAP

NEW APPLICATION ENTERED

08/25/2014

Continuous trademark protection

Get notified about every new filing that threatens EXCEED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.